Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs.
Mutation of the tumor suppressor p53 plays a major role in human carcinogenesis. Here we describe gene-targeted porcine mesenchymal stem cells (MSCs) and live pigs carrying a latent TP53(R167H) mutant allele, orthologous to oncogenic human mutant TP53(R175H) and mouse Trp53(R172H), that can be activ...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0808a3ff409d4bf4a547bbad43b1616a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0808a3ff409d4bf4a547bbad43b1616a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0808a3ff409d4bf4a547bbad43b1616a2021-11-18T08:13:08ZInactivation and inducible oncogenic mutation of p53 in gene targeted pigs.1932-620310.1371/journal.pone.0043323https://doaj.org/article/0808a3ff409d4bf4a547bbad43b1616a2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23071491/?tool=EBIhttps://doaj.org/toc/1932-6203Mutation of the tumor suppressor p53 plays a major role in human carcinogenesis. Here we describe gene-targeted porcine mesenchymal stem cells (MSCs) and live pigs carrying a latent TP53(R167H) mutant allele, orthologous to oncogenic human mutant TP53(R175H) and mouse Trp53(R172H), that can be activated by Cre recombination. MSCs carrying the latent TP53(R167H) mutant allele were analyzed in vitro. Homozygous cells were p53 deficient, and on continued culture exhibited more rapid proliferation, anchorage independent growth, and resistance to the apoptosis-inducing chemotherapeutic drug doxorubicin, all characteristic of cellular transformation. Cre mediated recombination activated the latent TP53(R167H) allele as predicted, and in homozygous cells expressed mutant p53-R167H protein at a level ten-fold greater than wild-type MSCs, consistent with the elevated levels found in human cancer cells. Gene targeted MSCs were used for nuclear transfer and fifteen viable piglets were produced carrying the latent TP53(R167H) mutant allele in heterozygous form. These animals will allow study of p53 deficiency and expression of mutant p53-R167H to model human germline, or spontaneous somatic p53 mutation. This work represents the first inactivation and mutation of the gatekeeper tumor suppressor gene TP53 in a non-rodent mammal.Simon LeuchsAnja SaalfrankClaudia MerklTatiana FlisikowskaMarlene EdlingerMarina DurkovicNousin RezaeiMayuko KuromeValeri ZakhartchenkoBarbara KesslerKrzysztof FlisikowskiAlexander KindEckhard WolfAngelika SchniekePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 10, p e43323 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Simon Leuchs Anja Saalfrank Claudia Merkl Tatiana Flisikowska Marlene Edlinger Marina Durkovic Nousin Rezaei Mayuko Kurome Valeri Zakhartchenko Barbara Kessler Krzysztof Flisikowski Alexander Kind Eckhard Wolf Angelika Schnieke Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| description |
Mutation of the tumor suppressor p53 plays a major role in human carcinogenesis. Here we describe gene-targeted porcine mesenchymal stem cells (MSCs) and live pigs carrying a latent TP53(R167H) mutant allele, orthologous to oncogenic human mutant TP53(R175H) and mouse Trp53(R172H), that can be activated by Cre recombination. MSCs carrying the latent TP53(R167H) mutant allele were analyzed in vitro. Homozygous cells were p53 deficient, and on continued culture exhibited more rapid proliferation, anchorage independent growth, and resistance to the apoptosis-inducing chemotherapeutic drug doxorubicin, all characteristic of cellular transformation. Cre mediated recombination activated the latent TP53(R167H) allele as predicted, and in homozygous cells expressed mutant p53-R167H protein at a level ten-fold greater than wild-type MSCs, consistent with the elevated levels found in human cancer cells. Gene targeted MSCs were used for nuclear transfer and fifteen viable piglets were produced carrying the latent TP53(R167H) mutant allele in heterozygous form. These animals will allow study of p53 deficiency and expression of mutant p53-R167H to model human germline, or spontaneous somatic p53 mutation. This work represents the first inactivation and mutation of the gatekeeper tumor suppressor gene TP53 in a non-rodent mammal. |
| format |
article |
| author |
Simon Leuchs Anja Saalfrank Claudia Merkl Tatiana Flisikowska Marlene Edlinger Marina Durkovic Nousin Rezaei Mayuko Kurome Valeri Zakhartchenko Barbara Kessler Krzysztof Flisikowski Alexander Kind Eckhard Wolf Angelika Schnieke |
| author_facet |
Simon Leuchs Anja Saalfrank Claudia Merkl Tatiana Flisikowska Marlene Edlinger Marina Durkovic Nousin Rezaei Mayuko Kurome Valeri Zakhartchenko Barbara Kessler Krzysztof Flisikowski Alexander Kind Eckhard Wolf Angelika Schnieke |
| author_sort |
Simon Leuchs |
| title |
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| title_short |
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| title_full |
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| title_fullStr |
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| title_full_unstemmed |
Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| title_sort |
inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/0808a3ff409d4bf4a547bbad43b1616a |
| work_keys_str_mv |
AT simonleuchs inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT anjasaalfrank inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT claudiamerkl inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT tatianaflisikowska inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT marleneedlinger inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT marinadurkovic inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT nousinrezaei inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT mayukokurome inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT valerizakhartchenko inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT barbarakessler inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT krzysztofflisikowski inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT alexanderkind inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT eckhardwolf inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs AT angelikaschnieke inactivationandinducibleoncogenicmutationofp53ingenetargetedpigs |
| _version_ |
1718422025561702400 |